Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

11.5K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of <i>Aster lautureanus</i> (Asteroideae, Asteraceae) Chloroplast Genome and Phylogenetic Insights.

Ecology and evolution·2026
Same author

Construction of selenium nanoparticles for the transmembrane absorption of <i>Polygonatum Sibiricum</i> polysaccharides and their antioxidant activity.

RSC advances·2026
Same author

Heterostructure engineering of integrated anti-perovskite electrode for high current density overall water splitting.

Chemical communications (Cambridge, England)·2026
Same author

Multiscale rational construction strategy for polyphenol self-assembled delivery systems: from nanoscale to microscale.

Materials today. Bio·2026
Same author

Discovery of highly selective and potent CYP1B1 inhibitors for overcoming paclitaxel resistance in A549/Taxol cells.

European journal of medicinal chemistry·2026
Same author

Effectiveness of Family Physician-Led Home-Based Long-Term Care on Quality of Life in Older Adults With Disability: A Quasi-Experimental Study.

Journal of the American Medical Directors Association·2026

Related Experiment Video

Updated: Jan 9, 2026

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

22.4K

AI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein Fibrils.

Jinfang Duan1,2, Haoyu Zhang1, Chuanqi Sun1,3

  • 1Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.

Cells
|December 10, 2025
PubMed
Summary

Researchers developed AI-designed peptides to inhibit alpha-synuclein (α-syn) fibril formation, a key process in Parkinson's disease. These peptides effectively reduced α-syn aggregation, offering a promising strategy for neurodegenerative disease treatment.

Keywords:
Parkinson’s diseaseartificial intelligencecryo-electron microscopypeptide inhibitor designstructural polymorphismα-synuclein fibrils

More Related Videos

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

9.1K
Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One &#945;-Synuclein Monomer at a Time
07:56

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time

Published on: May 30, 2021

3.5K

Related Experiment Videos

Last Updated: Jan 9, 2026

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

22.4K
Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

9.1K
Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One &#945;-Synuclein Monomer at a Time
07:56

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time

Published on: May 30, 2021

3.5K

Area of Science:

  • Biochemistry
  • Neuroscience
  • Computational Biology

Background:

  • Alpha-synuclein (α-syn) fibril formation with β-sheet structure is central to Parkinson's disease pathogenesis.
  • Diverse α-syn fibril polymorphs, revealed by Cryo-EM, complicate inhibitor design.

Purpose of the Study:

  • To design broad-spectrum peptide inhibitors targeting conserved β-sheet motifs in α-syn fibrils.
  • To leverage AI and structural data for rapid inhibitor discovery.

Main Methods:

  • Structure-guided framework integrating AI peptide generation (ProteinMPNN, AlphaFold-Multimer, PepMLM).
  • Assessing peptide efficacy via ThT fluorescence and aggregate morphology analysis.

Main Results:

  • Two peptides, T1 and S1, significantly inhibited α-syn fibrillation.
  • Inhibition correlated with predicted interface energies; observed aggregates were amorphous or fragmented.

Conclusions:

  • AI-driven computational design combined with Cryo-EM data enables rapid discovery of effective peptide inhibitors.
  • This approach is a promising strategy for precision treatment of neurodegenerative diseases like Parkinson's.